Adia Nutrition Inc.
Adia Nutrition Inc. (ADIA): 2 pipeline candidates · ~11 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
11.1 months
D/E -2.85
Lead: Approved
2 candidates
N/A
N/A
A transparent, data-derived signal for Adia Nutrition Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$15.1M
Cash
$137K
Quarterly Burn
$55K
Runway
11.1 mo
Revenue
$176K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Sep 2017Institutional holders
1
Total value held
$0
| Holder | Shares | Value |
|---|---|---|
| sevenbridge financial group, llc | 45,000 | $0 |
Frequently asked questions
How many drug candidates are in Adia Nutrition Inc.'s pipeline?
Adia Nutrition Inc. (ADIA) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Adia Nutrition Inc.'s lead drug candidate?
Adia Nutrition Inc.'s most advanced tracked candidate is adialink (Approved) for tissue repair and remodeling.
What is Adia Nutrition Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Adia Nutrition Inc. has approximately 11.1 months of cash runway.
What is Adia Nutrition Inc.'s market capitalization?
Adia Nutrition Inc.'s market capitalization is approximately $15.1M.
Who is the CEO of Adia Nutrition Inc.?
Mr. Larry Powalisz is the chief executive officer of Adia Nutrition Inc. (ADIA).
Get the full picture on Adia Nutrition Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.